[Skip to Content]

Clinical Trials for Cancer Treatment

Study Title:

Pilot study of the safety and feasibility of administering concurrent systemic chemotherapy with accelerated hypofractionated radiation therapy in the treatment of medically inoperable T1b and T2 Non-Small Cell Lung Cancer

What is the purpose of the study? (in Layman's terms, please describe the study)

The purpose of this research study is to see if adding chemotherapy during radiation therapy for patients with early stage lung cancer has acceptable side effects.

Upstate Institutional Review Board (IRB) Number:

665895

Study/Protocol ID:

Mix HypoFx Pilot Study

Study Phase:

Pilot

Patient Age Group:

Adults

Principal Investigator:

Michael D Mix, MD

What is involved if I participate?

  • How long is the study?
    4 cycles of treatment and then follow-up yearly.
  • Is transportation provided or reimbursed?
    No
  • Is parking provided or reimbursed?
    Yes
  • What tests and procedures are involved?
    Please contact the CRA for more information.

Where will the study take place?

Upstate Cancer Center - all procedures
The Hill Medical Center - all procedures
Oswego - all procedures
Oneida - all procedures

Other Information:

Please contact the CRA for more information.

ClinicalTrials.Gov ID:

NCT02619448

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Erin Bingham, CCRP
Phone: 315-464-3603
Email: binghame@upstate.edu

Return to Previous Page || Search Again

Top